Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Reduced
Aims Sodium-glucose cotransporter 2 inhibitors (SGLT2i) may induce an early post-initiation decrease of estimated glomerular filtration rate (eGFR), which does not impact the SGLT2i benefits. The occurrence, characteristics, determinants, and clinical significance of an initial eGFR change among pat...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
16 June 2022
|
| In: |
European journal of heart failure
Year: 2022, Jahrgang: 24, Heft: 10, Pages: 1829-1839 |
| ISSN: | 1879-0844 |
| DOI: | 10.1002/ejhf.2578 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/ejhf.2578 Verlag, lizenzpflichtig, Volltext: http://onlinelibrary.wiley.com/doi/abs/10.1002/ejhf.2578 
|
| Verfasserangaben: | Faiez Zannad, João Pedro Ferreira, John Gregson, Bettina Johanna Kraus, Michaela Mattheus, Sibylle Jenny Hauske, Javed Butler, Gerasimos Filippatos, Christoph Wanner, Stefan D. Anker, Stuart J. Pocock, and Milton Packer, for the EMPEROR-Reduced Trial Committees and Investigators |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1859265588 | ||
| 003 | DE-627 | ||
| 005 | 20240307084335.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230912s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ejhf.2578 |2 doi | |
| 035 | |a (DE-627)1859265588 | ||
| 035 | |a (DE-599)KXP1859265588 | ||
| 035 | |a (OCoLC)1425216838 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Zannad, Faiez |d 1951- |e VerfasserIn |0 (DE-588)141665009 |0 (DE-627)704036290 |0 (DE-576)182926400 |4 aut | |
| 245 | 1 | 0 | |a Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Reduced |c Faiez Zannad, João Pedro Ferreira, John Gregson, Bettina Johanna Kraus, Michaela Mattheus, Sibylle Jenny Hauske, Javed Butler, Gerasimos Filippatos, Christoph Wanner, Stefan D. Anker, Stuart J. Pocock, and Milton Packer, for the EMPEROR-Reduced Trial Committees and Investigators |
| 264 | 1 | |c 16 June 2022 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 12.09.2023 | ||
| 520 | |a Aims Sodium-glucose cotransporter 2 inhibitors (SGLT2i) may induce an early post-initiation decrease of estimated glomerular filtration rate (eGFR), which does not impact the SGLT2i benefits. The occurrence, characteristics, determinants, and clinical significance of an initial eGFR change among patients with heart failure with reduced ejection fraction require further study. In this study we aimed to describe eGFR change from randomization to week 4 (as percent of change relative to randomization) and assess its impact in EMPEROR-Reduced. Methods and results Landmark analyses (week 4) were performed. eGFR change was available in 3547 patients out of 3730 (95%). The tertiles of post-initiation % eGFR change for empagliflozin were: tertile 1 (T1) ≤−11.4%; T2 ≥−11.4% to ≤−1.0% and T3 ≥0.0%. The placebo group tertiles were: T1 ≤−6.5%; T2 ≥−6.4% to ≤+3.6%; and T3 ≥+3.6%. On average, empagliflozin induced a leftward distributional shift of initial eGFR changes of −2.5 ml/min/1.73 m2 versus placebo. In the empagliflozin group, after covariate adjustment, the risk of cardiovascular and renal outcomes did not differ between patients in whom early post-treatment initiation eGFR decreased (T1) and patients in whom it increased (T3). However, in the placebo group, patients in whom early post-treatment initiation eGFR decreased (T1) had a higher risk of sustained worsening kidney function and all-cause mortality compared to patients in whom eGFR increased (T3) (hazard ratio [HR] 2.38, 95% confidence interval [CI] 1.25-4.55 and HR 1.37, 95% CI 1.01-1.85, respectively). Conclusion A mild eGFR decrease may be expected after the initiation of empagliflozin, and it is not associated with untoward heart failure, mortality, or kidney safety events. Clinicians should not be concerned with early eGFR changes post-initiation of empagliflozin. | ||
| 650 | 4 | |a Empagliflozin | |
| 650 | 4 | |a Estimated glomerular filtration rate | |
| 650 | 4 | |a Heart failure with reduced ejection fraction | |
| 650 | 4 | |a Outcomes | |
| 700 | 1 | |a Ferreira, João Pedro |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gregson, John |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kraus, Bettina Johanna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mattheus, Michaela |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hauske, Sibylle J. |d 1976-2025 |e VerfasserIn |0 (DE-588)137856253 |0 (DE-627)596151527 |0 (DE-576)305349686 |4 aut | |
| 700 | 1 | |a Butler, Javed |e VerfasserIn |4 aut | |
| 700 | 1 | |a Filippatos, Gerasimos |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wanner, Christoph |e VerfasserIn |4 aut | |
| 700 | 1 | |a Anker, Stefan D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pocock, Stuart J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Packer, Milton |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of heart failure |d Oxford : Wiley, 1999 |g 24(2022), 10 vom: Okt., Seite 1829-1839 |h Online-Ressource |w (DE-627)306658291 |w (DE-600)1500332-2 |w (DE-576)081985983 |x 1879-0844 |7 nnas |a Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Reduced |
| 773 | 1 | 8 | |g volume:24 |g year:2022 |g number:10 |g month:10 |g pages:1829-1839 |g extent:11 |a Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Reduced |
| 856 | 4 | 0 | |u https://doi.org/10.1002/ejhf.2578 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://onlinelibrary.wiley.com/doi/abs/10.1002/ejhf.2578 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230912 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 137856253 |a Hauske, Sibylle J. |m 137856253:Hauske, Sibylle J. |d 60000 |d 61400 |e 60000PH137856253 |e 61400PH137856253 |k 0/60000/ |k 1/60000/61400/ |p 6 | ||
| 999 | |a KXP-PPN1859265588 |e 437450706X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Reduced","title_sort":"Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Reduced"}],"language":["eng"],"person":[{"display":"Zannad, Faiez","given":"Faiez","role":"aut","family":"Zannad"},{"family":"Ferreira","display":"Ferreira, João Pedro","given":"João Pedro","role":"aut"},{"family":"Gregson","display":"Gregson, John","given":"John","role":"aut"},{"role":"aut","given":"Bettina Johanna","display":"Kraus, Bettina Johanna","family":"Kraus"},{"given":"Michaela","role":"aut","display":"Mattheus, Michaela","family":"Mattheus"},{"given":"Sibylle J.","role":"aut","display":"Hauske, Sibylle J.","family":"Hauske"},{"given":"Javed","role":"aut","display":"Butler, Javed","family":"Butler"},{"display":"Filippatos, Gerasimos","role":"aut","given":"Gerasimos","family":"Filippatos"},{"display":"Wanner, Christoph","role":"aut","given":"Christoph","family":"Wanner"},{"display":"Anker, Stefan D.","role":"aut","given":"Stefan D.","family":"Anker"},{"family":"Pocock","display":"Pocock, Stuart J.","role":"aut","given":"Stuart J."},{"display":"Packer, Milton","role":"aut","given":"Milton","family":"Packer"}],"name":{"displayForm":["Faiez Zannad, João Pedro Ferreira, John Gregson, Bettina Johanna Kraus, Michaela Mattheus, Sibylle Jenny Hauske, Javed Butler, Gerasimos Filippatos, Christoph Wanner, Stefan D. Anker, Stuart J. Pocock, and Milton Packer, for the EMPEROR-Reduced Trial Committees and Investigators"]},"physDesc":[{"extent":"11 S."}],"id":{"doi":["10.1002/ejhf.2578"],"eki":["1859265588"]},"relHost":[{"language":["eng"],"part":{"text":"24(2022), 10 vom: Okt., Seite 1829-1839","year":"2022","volume":"24","issue":"10","pages":"1829-1839","extent":"11"},"title":[{"subtitle":"journal of the Working Group on Heart Failure of the European Society of Cardiology","title":"European journal of heart failure","title_sort":"European journal of heart failure"}],"pubHistory":["1.1999 -"],"note":["Gesehen am 07.01.25"],"disp":"Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-ReducedEuropean journal of heart failure","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["306658291"],"zdb":["1500332-2"],"issn":["1879-0844"],"doi":["10.1002/(ISSN)1879-0844"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"EJHF"}],"recId":"306658291","origin":[{"dateIssuedDisp":"1999-","publisher":"Oxford University Press ; Elsevier Science ; Oxford Univ. Press ; Wiley","dateIssuedKey":"1999","publisherPlace":"Oxford ; Amsterdam [u.a.] ; Oxford [u.a.] ; Oxford"}]}],"note":["Gesehen am 12.09.2023"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"16 June 2022","dateIssuedKey":"2022"}],"recId":"1859265588"} | ||
| SRT | |a ZANNADFAIEEARLYCHANG1620 | ||